A Single Mindfulness Meditation Session in Preoperative Anxiety : Effects on the Autonomous Nervous System
NCT ID: NCT03324048
Last Updated: 2019-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2017-11-14
2018-09-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary objective of this new study is to demonstrate a link between heart rate variability and reduced anxiety during relaxation session.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
NCT04562324
Effect of Brief Mindfulness and Relaxation Inductions on Anxiety, Affect and Brain Activation in Athletes
NCT05452629
Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli
NCT03206437
Influence of the Coloring of a Complex Form on Anxiety Associated With Care.
NCT03489980
Impact of Distance Meditation on Non-attachment to the Self and Identity Threat
NCT05285488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients anxious
Patients anxious will be perform relaxation session.
relaxation session
During relaxation session, patients anxious will have three electrodes for save heart rate variability and a sensor for save value of the partial pressure of carbon dioxide.
Before and after relaxation session, patient evaluates his anxiety by visual analogue scale (VAS) and State-Trait Anxiety Inventory (STAI-Y).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
relaxation session
During relaxation session, patients anxious will have three electrodes for save heart rate variability and a sensor for save value of the partial pressure of carbon dioxide.
Before and after relaxation session, patient evaluates his anxiety by visual analogue scale (VAS) and State-Trait Anxiety Inventory (STAI-Y).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have signed consent before their participation in the study
* Aged over 18 years
* Patients who will have an orthopedic surgery in full hospitalization
* Patients anxious on visual analogic scale of anxiety (\>5)
Exclusion Criteria
* Medical history of schizophrenia or bipolar disorder
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zeina PRADES, MD PhD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de SAINT-ETIENNE
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-RCB
Identifier Type: OTHER
Identifier Source: secondary_id
1708097
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.